TC BioPharm won the prestigious "High Growth Company of the Year (2017)" at Scotland's annual Life Science Awards held at the Glasgow Hilton.
The award reflects the fantastic progress TCB has made over the last 4 years including: Phase I/II oncology products in clinical development, proven in-house infrastructure to manufacture clinical product, established revenue generating partnerships, an innovative product development pipeline, £32m cash raised and over 60 amazing staff.
Thank you to everybody who has helped and supported us so far through this journey.
